Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China

In 2002, China integrated hepatitis B vaccine (HepB) into its Expanded Program on Immunization (EPI) using HepB vaccine containing 5 µg of antigen. Although not recommended nationally, there was a common clinical practice in China of screening children for anti-HBs antibody level and giving a booste...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Ning, Zheng, Hui, Sun, Xiaojin, Zhang, Guomin, Wang, Fuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584599/
https://www.ncbi.nlm.nih.gov/pubmed/33097788
http://dx.doi.org/10.1038/s41598-020-75338-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584599/
https://www.ncbi.nlm.nih.gov/pubmed/33097788
http://dx.doi.org/10.1038/s41598-020-75338-5

Ejemplares similares